Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 38 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Punctal and canalicular anatomy: Implications for canalicular occlusion in severe dry eyeKakizaki, H.; Takahashi, Y.; Iwaki, M.; Nakano, T.; Asamoto, K.; Ikeda, H.; Goto, E.; Selva-Nayagam, D.; Leibovitch, I.
2012Impact of age on choice of chemotherapy and outcome in advanced colorectal cancerKhattak, M.; Townsend, A.; Beeke, C.; Karapetis, C.; Luke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
2011Efficacy of α-lactalbumin and milk protein on weight loss and body composition during energy restrictionSoenen, S.; Hochstenbach-Waelen, A.; Westerterp-Plantenga, M.
2013Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17Vickers, M.; Karapetis, C.; Tu, D.; O'Callaghan, C.; Price, T.; Tebbutt, N.; van Hazel, G.; Shapiro, J.; Pavlakis, N.; Gibbs, P.; Blondal, J.; Lee, U.; Meharchand, J.; Burkes, R.; Rubin, S.; Simes, J.; Zalcberg, J.; Moore, M.; Zhu, L.; Jonker, D.
2011Anterior 180-degree partial fundoplication: A 16-year experience with 548 patientsChen, Z.; Thompson, S.; Jamieson, G.; Devitt, P.; Game, P.; Watson, D.
2012Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trialBurmeister, B.; Henderson, M.; Ainslie, J.; Fisher, R.; Di Iulio, J.; Smithers, B.; Hong, A.; Shannon, K.; Scolyer, R.; Carruthers, S.; Coventry, B.; Babington, S.; Duprat, J.; Hoekstra, H.; Thompson, J.
2011Composite grafts in eyelid reconstruction: The complications and outcomesCannon, P.; Madge, S.; Kakizaki, H.; Selva-Nayagam, D.
2010Treatment of ocular surface squamous neoplasia with Mitomycin CGupta, A.; Muecke, J.
2010Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancerPeeters, M.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; Andre, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; Tzekova, V.; Collins, S.; Oliner, K.; Rong, A.; Gansert, J.
2011Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancerPrice, T.; Hardingham, J.; Lee, C.; Weickhardt, A.; Townsend, A.; Wrin, J.; Chua, A.; Shivasami, A.; Cummins, M.; Murone, C.; Tebbutt, N.